Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “HIV”

Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income CountriesRecruiting
NCT06395129N/AUpdated Oct 1, 2025
Sponsor: Médecins du Monde
Drug Use · Hepatitis · Hiv
Armenia, Georgia, Tanzania
3BNC117 and 10-1074 in ART-treated IndividualsCompleted
NCT03526848Phase 1Updated Oct 1, 2025
Sponsor: Rockefeller University
Human Immunodeficiency Virus
United States
Experiential HIV Testing Increasing Testing Related Knowledge and Practice, and Reduce Stigma Toward HIV of Nurses.Completed
NCT05615935NAUpdated Oct 1, 2025
Sponsor: National Taiwan University
Hiv · HIV Testing
Taiwan
Physical Activity and People Living With HIV in New York CityTerminated
NCT07091253N/AUpdated Oct 1, 2025
Sponsor: Queens College, The City University of New York
HIV/AIDS
United States
Testing a Barbershop-based HIV Prevention Initiative Among MenCompleted
NCT06148584NAUpdated Oct 1, 2025
Sponsor: HIV Prevention Trials Network
HIV Infections
Uganda
PrEP Intervention in Prince George's County, MarylandRecruiting
NCT06141408NAUpdated Oct 1, 2025
Sponsor: George Mason University
Hiv · Mental Health Issue · Support, Family
United States
Comparative Autoantibody and Immunologic Cell Marker StudyEnrolling By Invitation
NCT02422875N/AUpdated Sep 30, 2025
Sponsor: Emory University
Autoimmune Diseases · Lupus Erythematosus, Systemic · Communicable Diseases
United States
Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected AdultsCompleted
NCT06039579Phase 2Updated Sep 30, 2025
Sponsor: ViiV Healthcare
HIV Infections
United States, Argentina, Canada, France, Germany +4 more
Adaptation and Implementation of Project Encuentro in the U.S.-Mexico BorderCompleted
NCT03293875NAUpdated Sep 26, 2025
Sponsor: City University of New York
HIV
United States, Mexico
Retrospective Review of DTG/3TC Versus BIC/F/TAF Across a Multi Clinic Infectious Disease Organization in Southeast United StatesCompleted
NCT06393387N/AUpdated Sep 26, 2025
Sponsor: Midway Specialty Care Center
Hiv · HIV-1-infection · HIV Infections
United States
Bone Mineral Density (BMD) in HIV InfectionTerminated
NCT00146094NAUpdated Sep 26, 2025
Sponsor: University Hospital, Strasbourg, France
Osteopenia · Osteoporosis
France
Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model to Eliminate Mother-to-Child Transmission of HIV in MalawiRecruiting
NCT06493357NAUpdated Sep 26, 2025
Sponsor: University of North Carolina, Chapel Hill
HIV Prevention
Malawi
Testing Strategies for Couple Engagement in PMTCT and Family Health in KenyaCompleted
NCT03547739NAUpdated Sep 26, 2025
Sponsor: University of Alabama at Birmingham
Human Immunodeficiency Virus
Kenya
Evaluating the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult ParticipantsCompleted
NCT03934541Phase 1Updated Sep 25, 2025
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
United States
Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based TherapyRecruiting
NCT05303337N/AUpdated Sep 25, 2025
Sponsor: Hôpital Européen Marseille
HIV Infections
France
Impact of Recombinant Human Growth Hormone on HIV PersistenceCompleted
NCT03091374Phase 2Updated Sep 25, 2025
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Human Immunodeficiency Virus · Growth Hormone Treatment
Canada
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good HealthRecruiting
NCT06796686Phase 1Updated Sep 25, 2025
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
HIV
United States
Investigating Point-of-care Diagnostics for Sexually Transmitted Infections and Antimicrobial Resistance in Primary Care in ZimbabweCompleted
NCT05541081NAUpdated Sep 25, 2025
Sponsor: London School of Hygiene and Tropical Medicine
Sexually Transmitted Infection · Chlamydia · Gonorrhea · Trichomoniasis
Zimbabwe
Microbiota Footprint and Frailty Phenotype in Virologically Suppressed People Living With HIVRecruiting
NCT05078957N/AUpdated Sep 25, 2025
Sponsor: Hôpital Européen Marseille
HIV Infections
France
HIV-to-HIV Transplant at MGHCompleted
NCT02750397N/AUpdated Sep 25, 2025
Sponsor: Massachusetts General Hospital
HIV · Awaiting Organ Transplant
United States
Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentRecruiting
NCT06497465Phase 3Updated Sep 24, 2025
Sponsor: Johns Hopkins University
Tuberculosis · HIV
Brazil
Peers Plus Mobile App for Treatment in HIVCompleted
NCT05427318NAUpdated Sep 24, 2025
Sponsor: San Diego State University
Human Immunodeficiency Virus
United States
Adherence Connection for Counseling, Education, and Support (ACCESS) IICompleted
NCT04499781NAUpdated Sep 24, 2025
Sponsor: NYU Langone Health
HIV Infections
United States
Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP"Completed
NCT05528653Phase 4Updated Sep 23, 2025
Sponsor: Vivent Health
HIV Prevention
United States
A Reinforcement Intervention for Increasing HIV Testing Among At-Risk WomenCompleted
NCT03768986NAUpdated Sep 23, 2025
Sponsor: UConn Health
HIV · HIV Testing · Women · Contingency Management
United States

Previous page Next page